With the FDA weighing a new Rx diet therapy, we review the anti-obesity sector. Noah Pines on the hype and hurdles for Vivus’s Qnexa and its would-be competitors, and the diabetes controversy
The mass-market, TV-and-print DTC formula is going the way of the vanishing primary care blockbusters it was designed to boost as new media and niche products fill the breach, Matthew Arnold reports
After six months in development, 200-year-old The New England Journal of Medicine has launched a new iPad app. The app will allow subscribers to markup and share Clinical Practice articles through email as well as on Twitter and Facebook. There will also be opportunities for app subscribers to create personal archives and access audio features.…
For those poring over the Sunshine Act’s fine print, the latest code of conduct guidelines from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) will seem mellow.
Several leadership organizations sent a letter to the Centers for Medicare and Medicaid Services urging it to exempt CME from a proposed rule related to the Physician Payments Sunshine Act so that faculty honoraria for accredited/certified CME activities and commercial support would be excluded from mandatory reporting requirements. The letter describes the role of ACCME’s…